NCT03451331 2024-05-16Gemcitabine + Carboplatin + Nivolumab Versus Gemcitabine + Oxaliplatin + Nivolumab in Cisplatin-ineligible Patients With Metastatic Urothelial CancerHoosier Cancer Research NetworkPhase 2 Completed49 enrolled 15 charts